Company Profile and Insights

Company

Open MedScience is a UK-registered company committed to advancing knowledge in medical imaging, radiochemistry, radiopharmaceutical science and radiotheranostics. The Company section provides a clear overview of our governance, leadership, policies and operational standards, ensuring transparency in how we publish, collaborate and innovate.

We operate within a defined governance framework that supports accountability, regulatory compliance and effective decision-making. As a Northern Ireland registered company, Open MedScience maintains formal company registration details and a registered office for statutory correspondence. We are registered with the Information Commissioner’s Office (ICO) and adhere to UK data protection legislation, ensuring that personal data is managed responsibly and securely. Compliance is not treated as an administrative exercise; it forms part of our commitment to professional integrity.

Editorial quality is central to our identity. All content is reviewed for accuracy, clarity and relevance prior to publication. Where appropriate, articles are informed by peer-reviewed research, established clinical guidance or trusted scientific sources. Our Corrections and Editorial Standards Policy outlines how we handle amendments or clarifications, reinforcing our belief that transparency strengthens credibility. By maintaining defined editorial processes, we support readers who rely on Open MedScience for professional development, academic reference and informed discussion.

Artificial intelligence supports, but does not replace, human oversight. Our AI Use Policy sets out the principles governing the responsible implementation of AI technologies across the platform. OpenMedAI, our conversational assistant, enhances content discovery and user engagement while remaining subject to editorial supervision. AI tools assist navigation and access to information; responsibility for published material remains firmly with the editorial leadership of Open MedScience.

The Company section also highlights our collaborative approach. We work with researchers, clinicians, technologists and industry specialists to explore developments in PET, SPECT, carbon-14 radiolabelling, targeted radiopharmaceutical therapies, artificial intelligence in imaging and emerging healthcare technologies. These collaborations enable informed discussion of diagnostic innovation, therapeutic advances and sustainable healthcare solutions.

Sustainability and wellbeing form part of our broader vision. We recognise that progress in medical science must align with environmental responsibility and professional wellbeing. By encouraging awareness of green healthcare technologies and responsible research practice, Open MedScience promotes approaches that support both patient outcomes and long-term scientific advancement.

This section serves as a central reference point for understanding how Open MedScience operates and the standards it upholds. Through structured governance, regulatory compliance, editorial responsibility and thoughtful innovation, we aim to provide reliable, accessible and ethically grounded scientific communication for the global medical imaging and radiopharmaceutical community.